The Value of Tracking Dementia and MCI in Large Population Based Trials

The value of tracking dementia and MCI in large, demographically representative samples like the HRS is important generally but also particularly around trying to understand brain health and cognitive decline. Every study has limitations, so can you talk a little bit about some of the potential limitations of your study? We are making these kinds of classifications or diagnostic classifications using much more limited information than would be typical in a full clinical exam.